Научно-Исследовательский Институт Реабилитации Инвалидов (Учебно-Научно-Лечебный Комплекс) Винницкого Национального Медицинского Университета Им. М.И. Пирогова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Научно-Исследовательский Институт Реабилитации Инвалидов (Учебно-Научно-Лечебный Комплекс) Винницкого Национального Медицинского Университета Им. М.И. ПироговаfiledCriticalНаучно-Исследовательский Институт Реабилитации Инвалидов (Учебно-Научно-Лечебный Комплекс) Винницкого Национального Медицинского Университета Им. М.И. Пирогова
Priority to UAU201302983UpriorityCriticalpatent/UA82673U/en
Publication of UA82673UpublicationCriticalpatent/UA82673U/en
Investigating Or Analysing Biological Materials
(AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
A method for treating the impaired union of the fracture comprises X-ray imaging, the assay for blood homocysteine and osteocalcin. When the level of homocysteine exceeds 15 µmol/L and the level of osteocalcin is less than 14 ng/mL, the courses of Decamevit and Osteogenon are prescribed.
UAU201302983U2013-03-112013-03-11Method for treating impaired union of fracture
UA82673U
(en)
Re:" how Hugh Hampton Young's treatment of President Woodrow Wilson's urinary retention and urosepsis affected the resolution of World War I," Fogg R, Kutikov A, Usso RG, Canter D, J urol 2011; 186 (3): 1153